Home
About Us
About Us
Board of Directors
Scientific Advisory Board
Management Team
Careers
For Researchers
Paxalisib
EVT801
Collaborating with Kazia
Publications and Presentations
For Partners
Our Current Partners
What We Are Looking For
For Patients
Accessing Kazia Drug Candidates in Clinical Trials
Accessing Kazia Drug Candidates for Compassionate Use
Resources for Patients
For Investors
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Media Centre
Overview
Video
Coverage
Contact
Contact Us
Subscribe to email alerts
Heading &
Sub-heading can be edited through HQI
Home
>
For Investors
>
Corporate Presentations
Press Releases
ASX Announcements
Delisting from ASX
How to convert unlisted shares to ADSs
SEC Filings
Corporate Presentations
Annual Reports
Financial Reports
AGM
Corporate Governance
Shareholder Services
Corporate Presentations
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
14-Dec-2020
Kazia presents to LD Micro Main Event
26-Nov-2020
Kazia presentation to Bell Potter Healthcare Conference
12-Nov-2020
Kazia presents to HCW Israel conference
1-Oct-2020
Kazia Investor Presentation
15-Sep-2020
Kazia presents to H C Wainwright conference
25-Jun-2020
Kazia presents to Hidden Gems ShareCafe Investor Webinar
22-Jun-2020
Kazia presents posters at AACR
16-Jun-2020
Kazia presentation to TKIRW
1-Jun-2020
Kazia presents interim paxalisib data to ASCO
20-Apr-2020
Kazia presents to Finance News Network
1
2
Next